MALONE MEDICAL CHAMBERS LTD

Company Registration Number:
NI636933 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

MALONE MEDICAL CHAMBERS LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

MALONE MEDICAL CHAMBERS LTD

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 26,996 40,498
Tangible assets: 4 3,190 4,395
Investments: 5 800,000 1,300,000
Total fixed assets: 830,186 1,344,893
Current assets
Cash at bank and in hand: 5,305 5,067
Total current assets: 5,305 5,067
Creditors: amounts falling due within one year: 6 (20,660) (83,197)
Net current assets (liabilities): (15,355) (78,130)
Total assets less current liabilities: 814,831 1,266,763
Creditors: amounts falling due after more than one year:   (477,247) (940,364)
Total net assets (liabilities): 337,584 326,399
Capital and reserves
Called up share capital: 12 12
Revaluation reserve:7250,000250,000
Profit and loss account: 87,572 76,387
Shareholders funds: 337,584 326,399

The notes form part of these financial statements

MALONE MEDICAL CHAMBERS LTD

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 09 January 2025
and signed on behalf of the board by:

Name: Dr Neil Thompson MD FRCS
Status: Director

The notes form part of these financial statements

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 3 6

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Intangible Assets

Total
Cost £
At 01 April 2023 135,003
At 31 March 2024 135,003
Amortisation
At 01 April 2023 94,505
Charge for year 13,502
At 31 March 2024 108,007
Net book value
At 31 March 2024 26,996
At 31 March 2023 40,498

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible Assets

Total
Cost £
At 01 April 2023 10,127
At 31 March 2024 10,127
Depreciation
At 01 April 2023 5,732
Charge for year 1,205
At 31 March 2024 6,937
Net book value
At 31 March 2024 3,190
At 31 March 2023 4,395

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Fixed investments

Investment Property comprises premises at 142 Malone Road, Belfast. The fair value of the investment property has been arrived at on the basis of a valuation carried out by the directors. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Creditors: amounts falling due within one year note

The bank loans are secured by charges over the properties situated at 142 Malone Road, Belfast and 573 Lisburn Road, Belfast.

MALONE MEDICAL CHAMBERS LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

7. Revaluation reserve

2024
£
Balance at 01 April 2023 250,000
Surplus or deficit after revaluation 0
Balance at 31 March 2024 250,000